These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16391537)

  • 21. Benefit of vaginal sildenafil citrate in assisted reproduction therapy.
    Paulus WE; Strehler E; Zhang M; Jelinkova L; El-Danasouri I; Sterzik K
    Fertil Steril; 2002 Apr; 77(4):846-7. PubMed ID: 11937147
    [No Abstract]   [Full Text] [Related]  

  • 22. Commentary on adjunctive use of testosterone gel with sildenafil for erectile dysfunction.
    Morales A
    J Urol; 2008 May; 179(5 Suppl):S103. PubMed ID: 18405738
    [No Abstract]   [Full Text] [Related]  

  • 23. What to do if Viagra won't do.
    Harv Mens Health Watch; 2005 May; 9(10):4-8. PubMed ID: 16044563
    [No Abstract]   [Full Text] [Related]  

  • 24. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
    Gregersen N; Jensen PT; Giraldi AE
    Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute myocardial infarction associated with sildenafil.
    López-Lázaro L; García-Arenillas M; Portolés-Pérez A; Vargas-Castrillón E; Moreno-González A
    Lancet; 1998 Dec; 352(9144):1936-7. PubMed ID: 9863817
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute angle-closure glaucoma following sildenafil citrate-aided sexual intercourse.
    Ramasamy B; Rowe F; Nayak H; Peckar C; Noonan C
    Acta Ophthalmol Scand; 2007 Mar; 85(2):229-30. PubMed ID: 17305747
    [No Abstract]   [Full Text] [Related]  

  • 27. Should phosphodiesterase 5 selective inhibitors be used for uterine relaxation?
    Méhats C; Schmitz T; Breuiller-Fouché M; Leroy MJ; Cabrol D
    Am J Obstet Gynecol; 2006 Jul; 195(1):184-5. PubMed ID: 16813753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction.
    Dunn ME; Althof SE; Perelman MA
    Int J Impot Res; 2007; 19(2):119-23. PubMed ID: 16738695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel therapeutic option in hypertensive crisis: sildenafil augments nitroprusside-induced hypotension.
    Bahadur MM; Aggarwal VD; Mali M; Thamba A
    Nephrol Dial Transplant; 2005 Jun; 20(6):1254-6. PubMed ID: 15784637
    [No Abstract]   [Full Text] [Related]  

  • 30. Optic atrophy after sildenafil use.
    Duszak R; Verghese M; Rinehart C; Alexander A
    Optometry; 2007 Jul; 78(7):329; author reply 329-30. PubMed ID: 17601569
    [No Abstract]   [Full Text] [Related]  

  • 31. Counseling patients about sexual issues.
    Stimmel GL; Gutierrez MA
    Pharmacotherapy; 2006 Nov; 26(11):1608-15. PubMed ID: 17064206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
    Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
    Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sexuality in relation to heart disease. What effect does a dialogue between doctor and patient have?].
    Berner MM
    Dtsch Med Wochenschr; 2002 Feb; 127(6):279-83. PubMed ID: 11832988
    [No Abstract]   [Full Text] [Related]  

  • 34. [Viagra vs a powerful Electuary?].
    Nau JY
    Rev Med Suisse; 2007 Dec; 3(136):2812. PubMed ID: 18183820
    [No Abstract]   [Full Text] [Related]  

  • 35. Ophthalmic aspects of erectile dysfunction drugs.
    Verit A; Oguz H
    Am J Ophthalmol; 2006 Mar; 141(3):598; author reply 599. PubMed ID: 16490529
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.
    Raja SG; Danton MD; MacArthur KJ; Pollock JC
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effectiveness duration determines selection].
    MMW Fortschr Med; 2006 Jul; 148(29-30):54-5. PubMed ID: 16910411
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
    Ghofrani HA; Grimminger F
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [7 years PDE-5 inhibitor for therapy of erection disorders].
    Krankenpfl J; 2005; 43(7-10):267. PubMed ID: 16518894
    [No Abstract]   [Full Text] [Related]  

  • 40. 3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors.
    Yoo J; Thai KM; Kim DK; Lee JY; Park HJ
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4271-4. PubMed ID: 17553682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.